Objective: There is no consensus on the definition of a hemodynamically significant patent ductus arteriosus (hsPDA). In this review article, our objective is to discuss the main variables that one should consider when determining the hemodynamic significance of a PDA.
| HIS TORIC AL PER S PEC TIVE
In the past, an hsPDA in a newborn was diagnosed only by clinical signs, such as a systolic murmur, wide pulse pressure, bounding pulses, hyperactive precordium, pulmonary edema, and increased oxygen requirement. Then, in the 1970s, echocardiography was introduced into pediatric practice and providers began to more objectively assess the hemodynamic effects of the PDA. While the information gained from echocardiography was limited at the time, M-mode allowed for an assessment of the extra volume load due to the PDA shunt based on the diameter of the left atrium (LA) relative to a constant, the aortic root (Ao) diameter. In the 1980s, echocardiography technology advanced further as the heart structures could be visualized in two dimensions and as such the diameter of the ductus arteriosus started to be included in the assessment of hsPDA.
In the late 1990s and early 2000s, neonatologists became more interested in the direct assessment of the PDA using echocardiography and other monitoring technologies. With these technological advances, it has become apparent that clinical signs of hsPDA can lag behind echocardiographic signs. 1 Thus, a more comprehensive approach in defining hsPDA has emerged.
| APPROACHE S TO DEFINING hsPDA
Despite widespread recognition of the importance of identifying an hsPDA, there remains no consensus on its definition. There are several approaches to defining an hsPDA. One approach is to qualify and quantify the hemodynamic effects of the PDA using clinical signs, echocardiographic parameters, and other objective assessments, and define a threshold to declare a PDA as hemodynamically significant.
Another approach would be to assess the need for treatment, which entails using various parameters to identify a PDA that would have high likelihood of remaining open or presenting with adverse hemodynamic effects. For example, choosing a cut-off diameter of 1.5 mm or 2 mm in an extremely preterm infant in the first couple of days of life to label it hsPDA and thus treat it. Lastly, an hsPDA could be defined based on probable outcomes. In this approach, the focus is on defining the population at risk for major complications of prematurity where the PDA is thought to play a role in the pathogenesis of said complication (eg, peri/intraventricular hemorrhage, pulmonary hemorrhage, bronchopulmonary dysplasia, necrotizing enterocolitis, etc.).
In defining an hsPDA, the hemodynamic effects of a PDA could be best evaluated using echocardiography, organ blood flow Doppler, and other available modalities. Additionally, the vulnerability of a given patient or population should be taken into account, including risk factors such as of perinatal variables, gestational age, chronologic age, and genetics.
| ECHOC ARDIOG R APHIC DE TERMINANTS IN DEFINING AN hsPDA
There are several echocardiographic indices that are helpful in evaluating for an hsPDA. These indices can be categorized into: the PDA shunt size, the extent of volume overload, the degree of pulmonary overflow, and the magnitude of systemic hypoperfusion ( Figure 1 ).
The PDA shunt can be characterized by the diameter and the flow pattern through the PDA. The PDA can be visualized using the The bidirectional pattern usually signifies elevated pulmonary blood pressure. The growing and pulsatile patterns indicate significant leftto-right shunt through the PDA and are thus suggestive of an hsPDA.
The closing pattern in general is suggestive of ductal constriction.
The diameter and the flow are related and may be complementary in identifying hsPDA. For example, one study showed that the closing pattern was most commonly seen in PDAs with smaller diameter, but there is a considerable overlap in the diameter size among the four groups. 4 Since the PDA shunt can now be described in detail Cerebral blood flow is altered in the presence of an hsPDA. [6] [7] [8] Low blood flow in the splanchnic and renal arteries in the presence of an hsPDA has also been described. 9 Major arteries supplying various organs (eg, anterior or middle cerebral artery, superior mesenteric artery, and renal artery) can be assessed using Doppler.
Normally, antegrade organ blood flow is detected both in the systole and diastole. In an hsPDA, decreased flow can be seen in both the systole and diastole, or diastolic blood flow may be absent or even reversed. While low organ blood flows have been noted in hsPDA, the impact of an hsPDA on regional cerebral, splanchnic, and renal oxygenation as measured by near infrared spectroscopy has been variably reported. [10] [11] [12] [13] [14] This variability is likely in large part due to differences in the studied population including the PDA characteristics.
Further work needs to be done to clarify the effects of an hsPDA on organ perfusion and oxygenation.
| P OPUL ATI ON S V ULNER AB LE TO hsPDA
In deciding which PDAs are hemodynamically significant, in addition to the PDA characteristics, vulnerability of the specific patient or population must be taken into account. Among the many risk factors that may contribute to the development of hsPDA, gestational age and chronological age are key contributors.
PDA occurs commonly in infants born less than 29 weeks of gestation, with an incidence of 40%-55%. 15 Premature infants have physiologic impairment of spontaneous closure due to poor intrinsic tone caused by a thin muscular layer in the ductus. 16 In addition, the balance of vasoconstrictors and dilators favors patency. 17, 18 Given the known impairment of spontaneous ductal closure in premature infants, it is important to know how often extremely preterm infants are able to close the ductus without medical or surgical treatment. Koch et al prospectively studied the natural course of the ductus in very preterm infants with birth weight < 1000 grams. 19 Only 42 (34%) of the 122 studied subjects experienced spontaneous ductal closure by day 10 of life. Additionally, they found that those more likely to close the ductus were on average 27 weeks, and those less likely to have spontaneous closure were on average 25.6 weeks. Therefore, the younger group is at a higher risk for persistent PDA. A larger retrospective study by Semberova et al described the natural course of PDA in very low birth weight infants using conservative management. 20 Eighty-five percent of infants experienced spontaneous closure prior to discharge. However, it is important to note that infants <26 weeks of gestation, which is the age group at the highest risk of complications of prematurity, took the longest to close the ductus, with a median of 71 days. Additionally, 33 infants were excluded from the study due to death during the study period. Etiology of death included infection, severe intraventricular hemorrhage, necrotizing enterocolitis, and pulmonary hemorrhage, and many of these infants had a documented presence of a PDA. Therefore, spontaneous closure rate is lower in extremely premature infants (<26 weeks) and even when the ductus does close without treatment, it takes many weeks. As these extremely preterm infants are at a greatest risk for complications of prematurity, one
should have a lower threshold of treating ductus in this population.
Another factor in determining the significance of a PDA is chronological age. The potential consequences of an hsPDA on different organ systems depend somewhat on chronological age. Peri/ intraventricular hemorrhage (PIVH) occurs most often in the first few days of life, at a time when the PDA shunt is potentially large. As mentioned earlier, cerebral blood flow is altered in the presence of an hsPDA and this impairment in cerebral blood flow may play a role in the pathogenesis of PIVH. [21] [22] [23] PDA is also implicated in the development of pulmonary hemorrhage, a life-threatening complication that can occur in preterm infants usually in the first few days of life. As pulmonary vascular resistance begins to fall after birth, the shunt volume across a significant PDA increases, which leads to increased pulmonary blood flow, pulmonary edema and congestion, and eventually pulmonary hemorrhage. 24 A placebo-controlled randomized trial by Kluckow et al demonstrated that preterm infants <29 weeks with a large PDA who received indomethacin versus placebo within 12 hours of birth had significantly less early pulmonary hemorrhage (2% vs 21%). 25 While PIVH and pulmonary hemorrhage are life-threatening conditions associated with PDA that are usually faced within days after birth, there is also an association between PDA and the development of bronchopulmonary dysplasia (BPD) over time. The body may be able to compensate initially to this increase in pulmonary blood flow, but eventually pulmonary edema develops, leading to increased ventilatory support and supplemental oxygen, which are additional risk factors for BPD. 26 Although the pathogenesis of BPD is multifactorial, there is evidence that prolonged exposure to moderate-large PDA contributes to the development of BPD.
27-29 Table 1 summarizes the major factors to be considered when designating a PDA as hemodynamically significant. While the most commonly used echocardiographic indices in the table are useful in defining an hsPDA, the clinical factors, the risk category based on gestational age, and the risk of a particular organ injury based on the chronological age need to be incorporated in this definition, especially when considering pharmacological or surgical treatment. 
| PRED IC TING THE OUTCOME S OF AN hsPDA

| CON CLUS ION
The definition of an hsPDA continues to evolve. The hemodynamic significance of a PDA should be interpreted by considering the gestational and chronological age, and by assessing the vulnerability of organs at risk for overflow (the lungs), or hypoperfusion (eg, the brain, intestines, and kidneys). Assessment of multiple echocardiographic indices with organ blood flow Doppler is helpful in evaluating the hemodynamic significance of a PDA. Further work is needed to reach a consensus of how to define and manage an hsPDA.
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